SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-028437
Filing Date
2023-08-14
Accepted
2023-08-14 16:06:52
Documents
81
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1047676
2 ex10-1.htm EX-10.1 8605
3 ex10-2.htm EX-10.2 8482
4 ex31-1.htm EX-31.1 17175
5 ex31-2.htm EX-31.2 17880
6 ex32-1.htm EX-32.1 11256
  Complete submission text file 0001493152-23-028437.txt   6443362

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE invo-20230630.xsd EX-101.SCH 58191
8 XBRL CALCULATION FILE invo-20230630_cal.xml EX-101.CAL 59528
9 XBRL DEFINITION FILE invo-20230630_def.xml EX-101.DEF 250988
10 XBRL LABEL FILE invo-20230630_lab.xml EX-101.LAB 444565
11 XBRL PRESENTATION FILE invo-20230630_pre.xml EX-101.PRE 362837
75 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 894191
Mailing Address 5582 BROADCAST COURT SARASOTA FL 34240
Business Address 5582 BROADCAST COURT SARASOTA FL 34240 (978) 878-9505
INVO Bioscience, Inc. (Filer) CIK: 0001417926 (see all company filings)

IRS No.: 204036208 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39701 | Film No.: 231169939
SIC: 3841 Surgical & Medical Instruments & Apparatus